← Back to Clinical Trials
Recruiting NCT07618884

NCT07618884 TransREctus Sheath PrePeritoneal Procedure (TREPP) for Inguinal Hernia Repair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07618884
Status Recruiting
Phase
Sponsor Assiut University
Condition Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-04-15
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
trans rectus sheath extra-peritoneal procedure (TREPP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-04-15 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Inguinal hernia repair remains one of the most commonly performed surgical procedures worldwide. Tension-free repair with mesh augmentation is the predominant treatment option, either achieved by preperitoneal laparoscopic hernioplasty or Lichtenstein procedure (LP). As the recurrence rate is reduced to less than 5 % after mesh repair, nowadays, long-term morbidity associated with open inguinal hernia repair is mainly related to chronic postoperative inguinal pain (CPIP). Despite many hypotheses about the possible causes for CPIP, there is now consensus that involvement of inguinal nerves plays a major role. The trans rectus sheath extra-peritoneal procedure (TREPP) is a minimally invasive open approach utilizing the rectus sheath to access the preperitoneal space. It has shown promise in providing effective repair with potential advantages in cosmesis, postoperative pain, and recurrence rates. It is a medial approach avoiding the interference with the course of all (three) inguinal nerves through lateral abdominal wall.

Eligibility Criteria

Inclusion Criteria: * Adults with primary unilateral or bilateral inguinal hernia Exclusion Criteria: * Strangulated hernias. * Severe comorbidities precluding surgery ((ASA Class IV,V)

Contact & Investigator

Central Contact

Mohamad Raafat, MD

✉ mohamad_raafat10@yahoo.com

📞 0201067877622

Frequently Asked Questions

Who can join the NCT07618884 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07618884 currently recruiting?

Yes, NCT07618884 is actively recruiting participants. Contact the research team at mohamad_raafat10@yahoo.com for enrollment information.

Where is the NCT07618884 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT07618884 clinical trial?

NCT07618884 is sponsored by Assiut University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology